AB-FUBINACA, A SYNTHETIC CANNABINOID IN “FUNKY GREEN STUFF™”
Keywords:
AB-FUBINACA, Synthetic cannabinoids, Spice, Funky Green Stuff, Herbal scent, Spectral analysesAbstract
Objective: The objective of this research was to isolate and identify any potential synthetic cannabinoids disguised in the commercially available claimed-to-be herbal scent, known as “Funky Green Stuff™”.
Methods: Potential synthetic cannabinoids were extracted via percolating the content of the commercial herbal scent bag “Funky Green StuffTM” in methanol. Column chromatographic isolation afforded one main pure compound. Different spectral analyses established the identity of the isolated compound.
Results: Chromatographic purification afforded 372 mg (5.2% w/w enrichment ratio) of pure needle crystals. Spectral analyses revealed the identity of the isolated compound as the synthetic cannabinoid AB-FUBINACA, confirming the assumption that a synthetic cannabinoid was disguised as an herbal scent product.
Conclusion: Several scent herbal products, also known as “spice”, are used to disguise synthetic cannabinoids. Their detection proved to be troublesome since authentic standards are not yet available. The synthetic cannabinoid, AB-FUBINACA, was isolated from one of these products, and its identity was established based on its spectral data.
Downloads
References
Valtar K, Arrizabalaga P, Landry J-C. Editors. Designer drugs directory. Lausanne: Elsevier Science; 1998.
Schmidt M, Sharma A, Schifano F, Feinmannn C. Legal highs†on the net-Evaluation of UK-based Websites, products and product information. Forensic Sci Int 2011;206:92-7.
Auwӓrter V, Dresen S, Weinmann W, Müller M, Pütz, Ferreiros N. Spice and other herbal blends: Harmless incense or cannabinoid designer drugs? J Mass Spectrom 2009;44:832-7.
Compton D, Rice K, De Costa B, Razdan R, Melvin L, Johnson M, et al. Cannabinoid structureâ€activity relationships: Correlation of receptor binding and in vivo activities. J pharmacol Exp Ther 1993;265:218â€26.
Porter A, Felder C. The endocannabinoid nervous system: Unique opportunities for therapeutic intervention. Pharmacol Ther 2009;90:45â€60.
European Monitoring Centre for Drugs and Drug Addiction. Understanding the Spice†Phenomenon. Luxembourg: Office for Official Publications of the European Communities; 2009. p. 1-34.
Robinson L, Goonawardena AV, Pertwee R, Hampson RE, Platt B, Riedel G. Win 55,212-2 induced deficits in spatial learning are mediated by cholinergic hypofunction. Behav Brain Res 2010;208:584-92.
De Brabanter N, Deventera K, Stoveb V, Van Eenooa P. Synthetic cannabinoids: General considerations. Proc Belgian Royal Acad Med 2013;2:209-25.
United Nations Office on Drugs and Crime. Recommended methods for the identification and analysis of synthetic cannabinoid receptor agonists in seized materials. Vienna: United Nations Office, Publishing and Library Section; 2013. p. 1-56.
Schneir A, Cullen J, Binh T. Spice†girls: synthetic cannabinoid intoxication. J Emerg Med 2011;40:296-9.
Steup C. Untersuchung des Handelsproduktes Spiceâ€. THC Pharm GmbH 2008.
Vardakou I, Pistos C, Spiliopoulou C. Spice drugs as a new trend: Mode of action, identification, and legislation. Toxicol Lett 2010;197:157-62.
Uchiyama N, Kawamura M, Kikura-Hanajari R, Goda Y. Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015, JWH-200, and JWH-073 as designer drugs in illegal products. Forensic Toxicol 2010;29:25-37.
United Nations Office on Drugs and Crime. Synthetic cannabinoids in herbal products. Vienna: United Nations Office, Publishing and Library Section; 2011. p. 1-24.
Teske J, Weller J, Fieguth A, Rothämel T, Schulz Y, Tröger H. Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography–tandem mass spectrometry. J Chromatogr B: Anal Technol Biomed Life Sci 2010;878:2659-63.
Sobolevsky T, Prasolov I, Rodchenkov G. Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids. Drug Test Anal 2012;4:745-53.
Kim U, Jin M, Lee J, Han S, In M, Yoo H. Tentative identification of phase I metabolites of HU-210, a classical synthetic cannabinoid, by LC–MS/MS. J Pharm Biomed Anal 2012;64-65:26-34.
Zhang Q, Ma P, Cole R, Wang G. Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS/MS. Anal Bioanal Chem 2006;386:1345-55.
Lindigkeit R, Boehme A, Eiserloh I, Luebbecke M, Wiggermann M, Ernst L, et al. Spice: a never ending story? Forensic Sci Int 2009;191:58-63.
Schifano F, Corazza O, Deluca P, Davey Z, Di Furia L, Farre M, et al. Psychoactive drug or mystical incense? Overview of the online available information on spice products. Int J Culture Mental Health 2009;2:137-44.
Uchiyama N, Matsuda S, Wakana D, Kikura-Hanajiri R, Goda Y. New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products. Forensic Toxicol 2012;31:93-100.
Behonick G, Shanks K, Firchau D, Mathur G, Lynch C, Nashelsky M, et al. Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22. J Anal Toxicol 2014;38:559-62.